Expert Q&A: Full Approval for Alzheimer’s Blood Tests Not Far Off
Andreas Jeromin, PhD, chief scientific officer at ALZPath, discusses the current landscape of blood-based AD tests and their future.
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article